4 January 2021 ORYZON to present a corporate update and to hold multiple virtual corporate activities in January-2021
17 December 2020 ORYZON Launches Pioneering Schizophrenia Precision Medicine Study In Collaboration With Columbia Psychiatry
20 November 2020 Borderline Personality Disorder Day organized by the Spanish BPD Association, AMAI-TLP
11 November 2020 ORYZON to present further positive efficacy data from iadademstat ALICE Phase IIa trial at the 62nd Congress of the American Society of Hematology
10 November 2020 ORYZON receives approval to start PORTICO Phase IIb trial with vafidemstat in Borderline Personality Disorder